Lack of influence of somatic mutations on steroid gradients during Adrenal vein sampling in aldosterone-producing adenoma patients

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 657-663

  Oßwald, Andrea ^a   Fischer, Evelyn ^a   Degenhart, Christoph ^a   Quinkler, Marcus ^b   Bidlingmaier, Martin ^a   Pallauf, Anna ^a   Lang, Katharina ^c   Mussack, Thomas ^a   Hallfeldt, Klaus ^a   Beuschlein, Felix ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; HYDROCORTISONE;

ADRENAL VEIN SAMPLING; ADULT; ARTICLE; ATP1A1 GENE; ATP2B3 GENE; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; GENE; HUMAN; HUMAN TISSUE; KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SOMATIC MUTATION;

ADENOSINE TRIPHOSPHATASES; ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; AGE FACTORS; AGED; ALDOSTERONE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; SEX FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPECIMEN HANDLING; STEROIDS; VEINS;

EID: 84885093691     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0551     Document Type: Article

References (18)

1. Eide IK, Torjesen PA, Drolsum A, Babovic A & Lilledahl NP Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. Journal of Hypertension 2004 22 2217-2226. (doi:10.1097/00004872-200411000-00026)
2. Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, Volzke H, Beuschlein F, Seissler J, Rettig R, Felix SB et al. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. European Journal of Endocrinology 2012 167 7-15. (doi:10.1530/EJE-11-1013)
3. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. Journal of Clinical Endocrinology and Metabolism 2009 94 1125-1130. (doi:10.1210/jc.2008-2116)
4. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R & Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Archives of Internal Medicine 2008 168 80-85. (doi:10.1001/ archinternmed.2007.33)
5. Milliez P Girerd X, Plouin PF, Blacher J, Safar ME & Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology 2005 45 1243-1248. (doi:10.1016/j.jacc.2005. 01.015)
6. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P & Sechi LA. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007 50 911-918. (doi:10.1161/HYPERTENSI0NAHA.107.095448)
7. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr & Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 3266-3281. (doi:10.1210/jc.2008-0104)
8. Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ et al. KC channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011 331 768-772. (doi:10.1126/science.1198785)
9. Mulatero P, Monticone S, Rainey WE, Veglio F & Williams TA. Role of KCNJ5 in familial and sporadic primary aldosteronism. Nature Reviews. Endocrinology 2013 9 104-112. (doi:10.1038/nrendo. 2012.230)
10. Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012 59 592-598. (doi:10.1161/HYPERTENSI0NAHA.111.186478)
11. Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature Genetics 2013 45 440-444. (doi:10.1038/ng.2550)
12. Seccia TM, Mantero F, Letizia C, Kuppusamy M, Caroccia B, Barisa M, Cicala MV, Miotto D & Rossi GP Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. Journal of Clinical Endocrinology and Metabolism 2012 97 E2307-E2313. (doi:10.1210/jc.2012-2342)
13. Fischer E, Beuschlein F, Bidlingmaier M & Reincke M. Commentary on the Endocrine Society practice guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Reviews in Endocrine & Metabolic Disorders 2011 12 43-48. (doi:10.1007/s11154-011-9163- 7)
14. Mulatero P, Bertello C, Verhovez A, Rossato D, Giraudo G, Mengozzi G, Limerutti G, Avenatti E, Tizzani D & Veglio F. Differential diagnosis of primary aldosteronism subtypes. Current Hypertension Reports 2009 11 217-223. (doi:10.1007/s11906-009-0038-1)
15. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. Journal of the American College of Cardiology 2006 48 2293-2300. (doi:10.1016/j.jacc.2006. 07.059)
16. Betz MJ, Degenhart C, Fischer E, Pallauf A, Brand V, Linsenmaier U, Beuschlein F, Bidlingmaier M & Reincke M. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. European Journal of Endocrinology 2011 165 301-306. (doi:10.1530/EJE-11- 0287)
17. Akerstrom T, Crona J, Delgado Verdugo A, Starker LF, Cupisti K, Willenberg HS, Knoefel WT, Saeger W, Feller A, Ip J et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE 2012 7 e41926. (doi:10.1371/journal.pone.0041926)
18. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. Journal of Clinical Endocrinology and Metabolism 2012 97 1606-1614. (doi:10.1210/jc.2011-2830)